Ramsay Générale de Santé SA (GDS.PA)
EUR 11.5
(0.44%)
EUR 11.5
(0.44%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.94 Billion EUR | 5.91% |
| 2022 | 3.72 Billion EUR | 9.16% |
| 2021 | 3.41 Billion EUR | 6.44% |
| 2020 | 3.2 Billion EUR | 6.28% |
| 2019 | 3.01 Billion EUR | 9.37% |
| 2018 | 2.75 Billion EUR | 53.86% |
| 2017 | 1.79 Billion EUR | 0.12% |
| 2016 | 1.78 Billion EUR | 0.66% |
| 2015 | 1.77 Billion EUR | 29.95% |
| 2014 | 1.36 Billion EUR | -10.15% |
| 2013 | 1.52 Billion EUR | -2.82% |
| 2012 | 1.56 Billion EUR | -0.91% |
| 2011 | 1.58 Billion EUR | 1.35% |
| 2010 | 1.56 Billion EUR | -5.57% |
| 2009 | 1.65 Billion EUR | 4.09% |
| 2008 | 1.58 Billion EUR | 3.52% |
| 2007 | 1.53 Billion EUR | 9.2% |
| 2006 | 1.4 Billion EUR | 19.91% |
| 2005 | 1.17 Billion EUR | 14.73% |
| 2004 | 1.02 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 314.7 Million EUR | -32.89% |
| 2023 Q3 | 369.6 Million EUR | -12.62% |
| 2023 FY | 945.1 Million EUR | -74.61% |
| 2023 Q4 | 372.8 Million EUR | 0.87% |
| 2023 Q2 | 423 Million EUR | 34.41% |
| 2022 Q2 | 351.8 Million EUR | 27.6% |
| 2022 FY | 3.72 Billion EUR | 9.16% |
| 2022 Q4 | 468.9 Million EUR | 39.45% |
| 2022 Q3 | 336.25 Million EUR | -4.42% |
| 2022 Q1 | 275.7 Million EUR | 252.56% |
| 2021 Q4 | 78.2 Million EUR | -74.21% |
| 2021 FY | 3.41 Billion EUR | 6.44% |
| 2021 Q1 | 279.85 Million EUR | 299.22% |
| 2021 Q2 | 78.6 Million EUR | -71.91% |
| 2021 Q3 | 303.25 Million EUR | 285.81% |
| 2020 Q4 | 70.1 Million EUR | -75.45% |
| 2020 FY | 3.2 Billion EUR | 6.28% |
| 2020 Q3 | 285.5 Million EUR | 328.68% |
| 2020 Q2 | 66.6 Million EUR | -74.25% |
| 2020 Q1 | 258.65 Million EUR | 6.27% |
| 2019 Q1 | 298.4 Million EUR | -6.25% |
| 2019 Q2 | 418 Million EUR | 40.08% |
| 2019 Q3 | 213.35 Million EUR | -48.96% |
| 2019 Q4 | 243.4 Million EUR | 14.08% |
| 2019 FY | 3.01 Billion EUR | 9.37% |
| 2018 FY | 2.75 Billion EUR | 53.86% |
| 2018 Q4 | 318.3 Million EUR | -2.79% |
| 2018 Q3 | 327.45 Million EUR | 44.38% |
| 2018 Q2 | 226.8 Million EUR | 0.0% |
| 2018 Q1 | 226.8 Million EUR | 2.46% |
| 2017 Q4 | 221.35 Million EUR | 0.0% |
| 2017 Q3 | 221.35 Million EUR | 17.33% |
| 2017 Q1 | 188.65 Million EUR | -12.64% |
| 2017 Q2 | 188.65 Million EUR | 0.0% |
| 2017 FY | 1.79 Billion EUR | 0.12% |
| 2016 Q3 | 215.95 Million EUR | 10.83% |
| 2016 Q2 | 194.85 Million EUR | 0.0% |
| 2016 FY | 1.78 Billion EUR | 0.66% |
| 2016 Q1 | 194.85 Million EUR | -13.99% |
| 2016 Q4 | 215.95 Million EUR | 0.0% |
| 2015 Q1 | 182.65 Million EUR | 0.0% |
| 2015 FY | 1.77 Billion EUR | 29.95% |
| 2015 Q2 | 182.65 Million EUR | 0.0% |
| 2015 Q3 | 226.55 Million EUR | 24.04% |
| 2015 Q4 | 226.55 Million EUR | 0.0% |
| 2014 FY | 1.36 Billion EUR | -10.15% |
| 2014 Q2 | 224.6 Million EUR | -48.22% |
| 2014 Q1 | 433.8 Million EUR | 23.91% |
| 2013 Q3 | 359.5 Million EUR | -5.17% |
| 2013 Q1 | 340.8 Million EUR | -14.35% |
| 2013 Q2 | 379.1 Million EUR | 11.24% |
| 2013 FY | 1.52 Billion EUR | -2.82% |
| 2013 Q4 | 350.1 Million EUR | -2.61% |
| 2012 FY | 1.56 Billion EUR | -0.91% |
| 2012 Q4 | 397.9 Million EUR | -1.68% |
| 2012 Q3 | 404.7 Million EUR | 2.4% |
| 2012 Q2 | 395.2 Million EUR | 12.75% |
| 2012 Q1 | 350.5 Million EUR | -13.46% |
| 2011 Q3 | 415.9 Million EUR | 4.31% |
| 2011 Q4 | 405 Million EUR | -2.62% |
| 2011 Q2 | 398.7 Million EUR | 14.14% |
| 2011 FY | 1.58 Billion EUR | 1.35% |
| 2011 Q1 | 349.3 Million EUR | -17.48% |
| 2010 FY | 1.56 Billion EUR | -5.57% |
| 2010 Q1 | 344.4 Million EUR | -13.27% |
| 2010 Q2 | 400.8 Million EUR | 16.38% |
| 2010 Q3 | 417.7 Million EUR | 4.22% |
| 2010 Q4 | 423.3 Million EUR | 1.34% |
| 2009 Q2 | 432.1 Million EUR | 0.0% |
| 2009 FY | 1.65 Billion EUR | 4.09% |
| 2009 Q4 | 397.1 Million EUR | -4.93% |
| 2009 Q3 | 417.7 Million EUR | -3.33% |
| 2008 FY | 1.58 Billion EUR | 3.52% |
| 2007 FY | 1.53 Billion EUR | 9.2% |
| 2006 FY | 1.4 Billion EUR | 19.91% |
| 2005 FY | 1.17 Billion EUR | 14.73% |
| 2004 FY | 1.02 Billion EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Clariane SE | 381.78 Million EUR | -932.681% |
| LNA Santé SA | 82.71 Million EUR | -4666.775% |